ICON plc is a global clinical research organisation (CRO) headquartered in Dublin, Ireland, providing comprehensive drug and device development services to pharmaceutical, biotechnology, and medical device companies worldwide. One of the world’s largest CROs with approximately 42,000 employees across 100+ countries, ICON delivers clinical trials across all major therapeutic areas from early-phase through to commercialisation.